Beliefs Around Hypoglycemia and Their Impacts on Hypoglycemia Outcomes in Individuals with Type 1 Diabetes and High Risks for Hypoglycemia Despite Using Advanced Diabetes Technologies.
Journal
Diabetes care
ISSN: 1935-5548
Titre abrégé: Diabetes Care
Pays: United States
ID NLM: 7805975
Informations de publication
Date de publication:
01 03 2022
01 03 2022
Historique:
received:
20
06
2021
accepted:
29
11
2021
pubmed:
12
1
2022
medline:
11
3
2022
entrez:
11
1
2022
Statut:
ppublish
Résumé
This study aimed to 1) identify the frequency of severe and level 2 hypoglycemia presenting in individuals with type 1 diabetes using continuous glucose monitoring systems (CGMs), including those with concomitant closed-loop insulin pumps, in a clinical practice setting and 2) evaluate the impact of beliefs around hypoglycemia in the development of severe and level 2 hypoglycemia in this population. A cross-sectional survey study in adults with type 1 diabetes using CGMs >6 months was conducted at a large tertiary academic center. Participant demographics, 6-month severe hypoglycemia history, hypoglycemia beliefs (with the Attitude to Awareness of Hypoglycemia questionnaire), and 4-week CGM glucose data were collected. Statistical analysis was performed to assess the presentation of severe and level 2 hypoglycemia and identify associated risk factors. A total of 289 participants were recruited (including 257 participants with CGM data within the last 3 months). Of these, 25.6% experienced at least one severe hypoglycemic episode in the last 6 months, and 13.6% presented with ≥1% of time in level 2 hypoglycemia on CGMs. Reporting beliefs about prioritizing hyperglycemia avoidance was associated with severe hypoglycemia development (P < 0.001), while having beliefs of minimal concerns for hypoglycemia was associated with spending ≥1% of time in level 2 hypoglycemia (P = 0.038). Despite the use of advanced diabetes technologies, severe and level 2 hypoglycemia continues to occur in individuals with type 1 diabetes and high hypoglycemia risks. Human factors, including beliefs around hypoglycemia, may continue to impact the effectiveness of glucose self-management.
Identifiants
pubmed: 35015079
pii: 139256
doi: 10.2337/dc21-1285
pmc: PMC8918194
doi:
Substances chimiques
Blood Glucose
0
Hypoglycemic Agents
0
Insulin
0
Banques de données
figshare
['10.2337/figshare.17136467']
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
520-528Subventions
Organisme : NIDDK NIH HHS
ID : R01 DK118082
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK092926
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK020572
Pays : United States
Organisme : NIDDK NIH HHS
ID : K23 DK129724
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002240
Pays : United States
Informations de copyright
© 2022 by the American Diabetes Association.
Références
SAGE Open Med. 2014 Apr 03;2:2050312114527443
pubmed: 26770717
J Diabetes Investig. 2019 Mar;10(2):219-220
pubmed: 30175462
Diabetes Care. 2018 Dec;41(12):2625-2633
pubmed: 30327358
Diabetes Care. 2015 Apr;38(4):544-50
pubmed: 25552422
Diabet Med. 2021 May;38(5):e14528
pubmed: 33496979
Diabetes Care. 2017 Dec;40(12):1661-1667
pubmed: 28928117
Diabetes Technol Ther. 2019 Feb;21(2):66-72
pubmed: 30657336
Diabetes Care. 1994 Jul;17(7):697-703
pubmed: 7924780
JAMA. 2020 Jun 16;323(23):2397-2406
pubmed: 32543682
Diabetes Technol Ther. 2021 Mar;23(S1):S21-S26
pubmed: 33434439
Diabetes Care. 2020 Oct;43(10):e142-e143
pubmed: 32820010
Diabetes Care. 2019 Oct;42(10):1854-1864
pubmed: 31391200
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Sci Rep. 2020 Oct 23;10(1):18180
pubmed: 33097760
PLoS Med. 2014 Oct 07;11(10):e1001742
pubmed: 25289645
N Engl J Med. 2019 Oct 31;381(18):1707-1717
pubmed: 31618560
BMJ Open. 2019 Jun 16;9(6):e030356
pubmed: 31209097
Diabet Med. 2012 Mar;29(3):321-7
pubmed: 21913969
BMJ. 2010 Jan 08;340:b4909
pubmed: 20061358
Diabetes. 2014 May;63(5):1738-47
pubmed: 24757202
BMJ Open Diabetes Res Care. 2021 Jan;9(1):
pubmed: 33431600
Diabetes Care. 2017 Dec;40(12):1622-1630
pubmed: 29162582
Diabetes Care. 2021 Apr;44(4):969-975
pubmed: 33579715
J Endocr Soc. 2019 Nov 19;4(1):bvz005
pubmed: 31993548
J Diabetes. 2019 Sep;11(9):711-718
pubmed: 30983138
Diabetes Care. 2018 Aug;41(8):1783-1791
pubmed: 29903847
Diabetes Care. 2021 Jan;44(Suppl 1):S73-S84
pubmed: 33298417
Diabetes Care. 2017 Dec;40(12):1641-1643
pubmed: 29162584
J Diabetes Sci Technol. 2019 Jul;13(4):636-644
pubmed: 30841740
Diabetes Ther. 2021 Jan;12(1):441-451
pubmed: 33219468
Diabetologia. 2018 Apr;61(4):761-769
pubmed: 29423581
Diabetes Care. 1999 Mar;22 Suppl 2:B40-2
pubmed: 10097898
Expert Rev Med Devices. 2020 Jul;17(7):707-720
pubmed: 32569476
Diabetes Care. 2021 Jan;44(Suppl 1):S85-S99
pubmed: 33298418
Diabetes Care. 2019 Aug;42(8):1593-1603
pubmed: 31177185
N Engl J Med. 2013 Jul 25;369(4):362-72
pubmed: 23883381